Name:	O
___	O
Unit	O
No:	O
___	O
Admission	O
Date:	O
___	O
Discharge	O
Date:	O
___	O
Date	O
of	O
Birth:	O
___	O
Sex:	O
F	O
Service:	O
MEDICINE	O
Allergies:	O
Diltiazem	O
/	O
Norvasc	O
/	O
lisinopril	O
/	O
clonidine	O
/	O
Beta-Blockers	O
(Beta-Adrenergic	O
Blocking	O
Agts)	O
/	O
Neurontin	O
/	O
adhesive	O
Attending:	O
___.	O
Chief	O
Complaint:	O
Back	O
pain,	O
weakness,	O
fatigue	O
Major	O
Surgical	O
or	O
Invasive	O
Procedure:	O
None	O
History	O
of	O
Present	O
Illness:	O
___	O
year	O
old	O
woman	O
with	O
HTN,	O
Graves,	O
chronic	O
back	O
pain,	O
lymphedema,	O
uterine	O
prolapse	O
s/p	O
complicated	O
TAH/BSO	O
in	O
___	O
of	O
this	O
year,	O
who	O
presents	O
with	O
weakness,	O
back	O
pain,	O
BRBPR.	B-Lower_gastrointestinal_haemorrhage
She	O
was	O
found	O
to	O
have	O
T11	B-Vertebral_compression_fracture
compression	B-Vertebral_compression_fracture
fracture	B-Vertebral_compression_fracture
as	O
well	O
as	O
LLL	O
opacity,	O
3	O
cm,	O
concerning	O
for	O
malignancy.	O
History	O
is	O
obtained	O
mostly	O
through	O
chart	O
and	O
ED	O
signout,	O
as	O
pt	O
was	O
not	O
willing	O
kept	O
was	O
hanging	O
up	O
the	O
interpreter	O
phone.	O
She	O
has	O
had	O
repeat	O
hospital	O
stays	O
this	O
year	O
for	O
fall,	B-Falls
weakness,	O
and	O
once	O
for	O
aphasia	O
thought	O
to	O
be	O
due	O
to	O
an	O
episode	O
of	O
hypotension	O
and	O
L	O
M2	O
stenosis	O
and	O
was	O
found	O
to	O
have	O
punctate	O
ischemic	O
stroke	O
in	O
the	O
L	O
frontal	O
cortex.	O
History	O
is	O
limited	O
by	O
pt's	O
ability	O
to	O
give	O
chronologic	O
history	O
and	O
interrupted	O
by	O
her	O
current	O
symptoms.	O
She	O
has	O
felt	O
overall	O
globally	O
weak	O
since	O
her	O
TAH/BSO,	O
worse	O
in	O
the	O
past	O
week.	O
She	O
denied	O
focal	O
weakness	O
or	O
difficulty	O
accomplishing	O
specific	O
tasks,	O
just	O
an	O
overall	O
sense	O
of	O
feeling	O
tired	O
and	O
like	O
she	O
doesn't	O
have	O
enough	O
strength.	O
Overnight	O
on	O
the	O
___,	O
she	O
felt	O
so	O
weak	O
that	O
she	O
didn't	O
get	O
out	O
of	O
bed	O
to	O
go	O
to	O
the	O
bathroom.	O
This	O
is	O
what	O
prompted	O
her	O
to	O
come	O
to	O
the	O
ED.	O
She	O
recently	O
complained	O
of	O
DOE	O
at	O
cardiology	O
visit,	O
thought	O
to	O
be	O
due	O
to	O
?	O
lung	O
disease.	O
Her	O
BRBPR	B-Lower_gastrointestinal_haemorrhage
is	O
hard	O
to	O
quantify.	O
She	O
doesn't	O
say	O
she	O
has	O
hematochezia,	B-Lower_gastrointestinal_haemorrhage
blood	O
in	O
the	O
toilet,	O
with	O
wiping,	O
only	O
that	O
she	O
has	O
seen	O
bright	O
red	B-Lower_gastrointestinal_haemorrhage
blood	B-Lower_gastrointestinal_haemorrhage
in	O
the	O
stool.	B-Lower_gastrointestinal_haemorrhage
Her	O
rectal	O
exam	O
showed	O
no	O
stool	O
in	O
the	O
vault	O
but	O
"guaiac	O
positive	O
gel".	O
She	O
complained	O
of	O
worsening	O
back	O
pain,	O
and	O
given	O
history	O
of	O
urinary	B-Urinary_incontinence
incontinence	B-Urinary_incontinence
(	O
which	O
turned	O
out	O
to	O
be	O
chronic)	O
her	O
entire	O
neuroaxis	O
was	O
imaged	O
which	O
revealed	O
T12	B-Vertebral_compression_fracture
anterior	O
superior	O
corner	O
fracture.	B-Vertebral_compression_fracture
She	O
reports	O
a	O
fall	O
when	O
visiting	O
her	O
cardiologist	O
(Dr	O
___,	O
for	O
which	O
a	O
rapid	O
response	O
was	O
called.	O
She	O
chose	O
not	O
to	O
go	O
to	O
the	O
ED.	O
Orthospine	O
was	O
consulted	O
in	O
the	O
ED,	O
who	O
recommended	O
TLSO	O
brace.	O
Her	O
imaging	O
also	O
revealed	O
3.1	O
cm	O
peribronchial	O
opacity	O
in	O
LLL	O
c/f	O
malignancy,	O
as	O
it	O
was	O
unchanged	O
from	O
___	O
image.	O
She	O
was	O
started	O
on	O
ceftriaxone	O
for	O
presumed	O
UTI.	B-Urinary_tract_infection
In	O
the	O
ED,	O
initial	O
vitals:	O
T	O
97.7	O
HR68	O
BP130/80	O
RR18	O
97%	O
RA	O
Labs	O
were	O
significant	O
for:	O
UA	O
with	O
nitrities,	O
large	O
leuks,	O
and	O
175	O
WBC	O
Cr	O
1.2	O
from	O
baseline	O
0.9	O
CK:	O
367	O
Imaging	O
of	O
her	O
entire	O
neuroaxis	O
revealed:	O
T-Spine	O
1.	O
New	O
T12	B-Vertebral_compression_fracture
anterior	O
superior	O
corner	O
fracture	B-Vertebral_compression_fracture
compared	O
to	O
___	O
with	O
mild	O
loss	O
of	O
height.	O
No	O
retropulsion.	O
Minimal	O
prevertebral	O
hematoma.	O
2.	O
3.1	O
cm	O
peribronchial	O
opacity	O
in	O
the	O
superior	O
segment	O
of	O
the	O
left	O
lower	O
lobe,	O
solid	O
medial	O
and	O
ground-glass	O
laterally,	O
is	O
unchanged	O
compared	O
to	O
the	O
motion	O
limited	O
___llowing	O
for	O
differences	O
in	O
technique.	O
Malignancy	O
cannot	O
be	O
excluded.	O
L-Spine	O
1.	O
No	O
evidence	O
for	O
a	O
fracture	B-Vertebral_compression_fracture
in	O
the	O
lumbar	O
spine.	B-Vertebral_compression_fracture
2.	O
Multilevel	O
lumbar	O
spine	O
degenerative	O
disc	O
disease.	O
Mild	O
spinal	O
canal	O
narrowing	O
at	O
L3-L4	O
and	O
L4-L5.	O
Moderate	O
left	O
L3-L4,	O
bilateral	O
L4-L5,	O
and	O
right	O
L5-S1	O
neural	O
foraminal	O
narrowing.	O
Severe	O
left	O
L5-S1	O
neural	O
foraminal	O
narrowing.	O
3.	O
Partially	O
imaged	O
T12	B-Vertebral_compression_fracture
compression	B-Vertebral_compression_fracture
fracture	B-Vertebral_compression_fracture
is	O
better	O
assessed	O
on	O
the	O
same-day	O
thoracic	O
spine	B-Vertebral_compression_fracture
CT.	O
C-spine	I-Vertebral_compression_fracture
IMPRESSION:	O
1.	O
Mildly	O
motion	O
limited	O
exam.	O
2.	O
No	O
evidence	O
for	O
a	O
fracture.	B-Vertebral_compression_fracture
No	O
subluxation.	O
3.	O
Multilevel	O
degenerative	O
disease.	O
In	O
the	O
ED,	O
pt	O
received	O
___	O
15:11	O
IV	O
CefTRIAXone	O
___	O
12:26	O
IV	O
Magnesium	O
Sulfate	O
2	O
gm	O
Vitals	O
prior	O
to	O
transfer:	O
HR	O
62	O
BP121/59	O
RR16	O
99%	O
RA	O
On	O
the	O
floor,	O
the	O
patient	O
is	O
interviewed	O
with	O
phone	O
at	O
bedside.	O
She	O
is	O
thankful	O
for	O
the	O
care	O
she	O
has	O
received	O
so	O
far	O
but	O
is	O
tired	O
and	O
does	O
not	O
wish	O
to	O
engage	O
in	O
another	O
interview	O
and	O
repeatedly	O
hangs	O
up	O
the	O
phone.	O
She	O
confirms	O
many	O
aspects	O
of	O
the	O
above	O
story.	O
Past	O
Medical	O
History:	O
Asthma	O
HTN	O
NIDDM	O
Grave's	O
disease	O
Chronic	O
back	O
pain	O
Lymphedema	O
HFpEF	O
(mild)	O
Bladder/uterine	O
prolapse	O
s/p	O
TAH/BSO	O
(complicated	O
by	O
hemoperitoneum)	O
Recent	O
punctate	O
ischemic	O
stroke	O
Social	O
History:	O
___	O
Family	O
History:	O
No	O
FH	O
of	O
thyroid	O
diseases.	O
Family	O
history	O
significant	O
for	O
mother	O
and	O
multiple	O
aunts	O
with	O
CAD	O
and	O
CHF.	O
Physical	O
Exam:	O
ADMISSION	O
PHYSICAL	O
EXAM	O
======================	O
VS:	O
Temp:	O
98.5	O
(Tm	O
98.5),	O
BP:	O
129/67,	O
HR:	O
63,	O
RR:	O
18,	O
O2	O
sat:	O
96%,	O
O2	O
delivery:	O
Ra,	O
Wt:	O
178.79	O
lb/81.1	O
kg	O
GEN:	O
sitting	O
up	O
in	O
bed	O
comfortable	O
drinking	O
tea	O
HEENT:	O
Moist	O
MM,	O
anicteric	O
sclerae,	O
no	O
conjunctival	O
pallor	O
NECK:	O
Supple	O
without	O
LAD	O
PULM:	O
Generally	O
CTA	O
b/l	O
without	O
rare	O
wheezes	O
COR:	O
RRR	O
(+)S1/S2	O
no	O
m/r/g	O
ABD:	O
Soft,	O
non-tender,	O
non-distended	O
EXTREM:	O
Warm,	O
well-perfused,	O
lymphedema,	O
___	O
wrapped	O
NEURO:	O
CN	O
II-XII	O
grossly	O
intact,	O
motor	O
function	O
grossly	O
normal.	O
Strong	O
throughout.	O
DISCHARGE	O
PHYSICAL	O
EXAM	O
======================	O
GEN:	O
sitting	O
up	O
in	O
bed	O
comfortable	O
HEENT:	O
Moist	O
MM,	O
anicteric	O
sclerae,	O
no	O
conjunctival	O
pallor	O
NECK:	O
Supple	O
without	O
LAD	O
PULM:	O
CTA	O
b/l	O
without	O
r/r/w	O
COR:	O
RRR	O
(+)S1/S2	O
no	O
m/r/g	O
ABD:	O
Soft,	O
non-tender,	O
non-distended	O
EXTREM:	O
Warm,	O
well-perfused,	O
lymphedema,	O
___	O
wrapped	O
NEURO:	O
CN	O
II-XII	O
grossly	O
intact,	O
motor	O
function	O
grossly	O
normal.	O
Strong	O
throughout.	O
Pertinent	O
Results:	O
ADMISSION	O
LABS	O
=============	O
___	O
09:10AM	O
BLOOD	O
WBC-8.1	O
RBC-3.73*	O
Hgb-11.2	O
Hct-34.1	O
MCV-91	O
MCH-30.0	O
MCHC-32.8	O
RDW-14.2	O
RDWSD-47.3*	O
Plt	O
___	O
___	O
09:10AM	O
BLOOD	O
Neuts-66.8	O
Lymphs-16.5*	O
Monos-11.3	O
Eos-4.3	O
Baso-0.5	O
Im	O
___	O
AbsNeut-5.41	O
AbsLymp-1.34	O
AbsMono-0.92*	O
AbsEos-0.35	O
AbsBaso-0.04	O
___	O
09:13AM	O
BLOOD	O
___	O
PTT-28.8	O
___	O
___	O
09:10AM	O
BLOOD	O
Glucose-226*	O
UreaN-36*	O
Creat-1.2*	O
Na-144	O
K-3.9	O
Cl-104	O
HCO3-24	O
AnGap-16	O
___	O
07:15AM	O
BLOOD	O
ALT-13	O
AST-16	O
LD(LDH)-191	O
CK(CPK)-170	O
AlkPhos-85	O
TotBili-0.4	O
___	O
09:10AM	O
BLOOD	O
CK(CPK)-367*	O
___	O
09:10AM	O
BLOOD	O
CK-MB-6	O
cTropnT-0.03*	O
___	O
07:40AM	O
BLOOD	O
CK-MB-2	O
cTropnT-0.01	O
___	O
09:10AM	O
BLOOD	O
Calcium-9.4	O
Phos-3.0	O
Mg-1.2*	O
___	O
10:15AM	O
BLOOD	O
TSH-3.4	O
___	O
07:15AM	O
BLOOD	O
25VitD-48	O
___	O
07:07AM	O
BLOOD	O
CRP-11.7*	O
___	O
09:16AM	O
BLOOD	O
Glucose-219*	O
Lactate-1.4	O
MICROBIOLOGY	O
============	O
___	O
2:21	O
pm	O
URINE	O
**FINAL	O
REPORT	O
___	O
URINE	O
CULTURE	O
(Final	O
___:	O
ENTEROBACTER	O
CLOACAE	O
COMPLEX.	O
>100,000	O
CFU/mL.	O
Cefepime	O
test	O
result	O
confirmed	O
by	O
___.	O
Piperacillin/Tazobactam	O
test	O
result	O
performed	O
by	O
___	O
___.	O
SENSITIVITIES:	O
MIC	O
expressed	O
in	O
MCG/ML	O
_________________________________________________________	O
ENTEROBACTER	O
CLOACAE	O
COMPLEX	O
|	O
CEFEPIME--------------	O
<=1	O
S	O
CEFTAZIDIME-----------	O
=>64	O
R	O
CEFTRIAXONE-----------	O
16	O
R	O
CIPROFLOXACIN---------<=0.25	O
S	O
GENTAMICIN------------	O
<=1	O
S	O
MEROPENEM-------------<=0.25	O
S	O
NITROFURANTOIN--------	O
<=16	O
S	O
PIPERACILLIN/TAZO-----	O
I	O
TOBRAMYCIN------------	O
<=1	O
S	O
TRIMETHOPRIM/SULFA----	O
<=1	O
S	O
IMAGING	O
=======	O
CXR	O
___:	O
No	O
evidence	O
of	O
pneumonia.	B-Lower_respiratory_tract_infection
NCHCT	O
___:	O
No	O
evidence	O
for	O
acute	O
intracranial	O
abnormalities	O
or	O
displaced	O
fracture.	O
CT	B-Vertebral_compression_fracture
L-SPINE	I-Vertebral_compression_fracture
___:	O
1.	O
No	O
evidence	O
for	O
a	O
fracture	B-Vertebral_compression_fracture
in	O
the	O
lumbar	O
spine.	B-Vertebral_compression_fracture
2.	O
Multilevel	O
lumbar	O
spine	O
degenerative	O
disc	O
disease.	O
Mild	O
spinal	O
canal	O
narrowing	O
at	O
L3-L4	O
and	O
L4-L5.	O
Moderate	O
left	O
L3-L4,	O
bilateral	O
L4-L5,	O
and	O
right	O
L5-S1	O
neural	O
foraminal	O
narrowing.	O
Severe	O
left	O
L5-S1	O
neural	O
foraminal	O
narrowing.	O
3.	O
Partially	O
imaged	O
T12	B-Vertebral_compression_fracture
compression	B-Vertebral_compression_fracture
fracture	B-Vertebral_compression_fracture
is	O
better	O
assessed	O
on	O
the	O
same-day	O
thoracic	O
spine	B-Vertebral_compression_fracture
CT.	B-Vertebral_compression_fracture
CT	B-Vertebral_compression_fracture
T-SPINE	I-Vertebral_compression_fracture
___:	O
1.	O
New	O
T12	B-Vertebral_compression_fracture
anterior	O
superior	O
corner	O
fracture	B-Vertebral_compression_fracture
compared	O
to	O
___	O
with	O
mild	O
loss	O
of	O
height.	O
No	O
retropulsion.	O
Minimal	O
prevertebral	O
hematoma.	O
2.	O
3.1	O
cm	O
peribronchial	O
opacity	O
in	O
the	O
superior	O
segment	O
of	O
the	O
left	O
lower	O
lobe,	O
solid	O
medial	O
and	O
ground-glass	O
laterally,	O
is	O
unchanged	O
compared	O
to	O
the	O
motion	O
limited	O
___llowing	O
for	O
differences	O
in	O
technique.	O
Malignancy	O
cannot	O
be	O
excluded.	O
CT	O
C-SPINE	I-Vertebral_compression_fracture
___:	O
1.	O
Mildly	O
motion	O
limited	O
exam.	O
2.	O
No	O
evidence	O
for	O
a	O
fracture.	B-Vertebral_compression_fracture
No	O
subluxation.	O
3.	O
Multilevel	O
degenerative	O
disease.	O
CT	O
CHEST	O
WITH	O
CONTRAST	O
___:	O
Possible	O
bronchogenic	O
carcinoma,	O
superior	O
segment	O
left	O
lower	O
lobe.	O
No	O
evidence	O
of	O
metastasis.	O
Chronic	O
thyromegaly	O
may	O
reflect	O
thyroid	O
dysfunction.	O
No	O
discrete	O
lesion.	O
Bulbous	O
character,	O
gastroesophageal	O
junction,	O
would	O
require	O
contrast	O
swallow	O
for	O
evaluation.	O
No	O
indirect	O
evidence	O
of	O
obstruction.	O
Atherosclerotic	O
calcification	O
heavy,	O
coronaries,	O
left	O
subclavian	O
artery.	O
Aortic	O
valvular	O
calcification	O
moderate.	O
CT	O
A/P	O
WITH	O
CONTRAST	O
___:	O
1.	O
No	O
evidence	O
of	O
metastatic	O
disease	O
or	O
lymphadenopathy	O
in	O
the	O
abdomen	O
or	O
pelvis.	O
2.	O
When	O
compared	O
to	O
study	O
dated	O
___,	O
there	O
is	O
a	O
new	O
compression	O
deformity	O
of	O
the	O
superior	O
endplate	O
of	O
T12	O
with	O
less	O
than	O
50%	O
vertebral	O
body	O
height	O
loss	O
and	O
no	O
bony	O
retropulsion	O
within	O
the	O
spinal	O
canal.	O
Please	O
correlate	O
the	O
aforementioned	O
finding	O
with	O
possible	O
history	O
of	O
prior	O
trauma.	O
3.	O
The	O
bladder	O
is	O
moderately	O
distended	O
bladder	O
with	O
mild	O
wall	O
thickening	O
at	O
the	O
posterior	O
base.	O
If	O
there	O
is	O
a	O
history	O
of	O
hematuria,	O
correlation	O
with	O
cystoscopy	O
may	O
be	O
considered.	O
DISCHARGE/INTERVAL	O
LABS	O
=======================	O
___	O
07:40AM	O
BLOOD	O
WBC-7.2	O
RBC-3.56*	O
Hgb-10.9*	O
Hct-33.6*	O
MCV-94	O
MCH-30.6	O
MCHC-32.4	O
RDW-14.1	O
RDWSD-47.4*	O
Plt	O
___	O
___	O
06:10AM	O
BLOOD	O
WBC-7.4	O
RBC-3.79*	O
Hgb-11.4	O
Hct-38.3	O
MCV-101*	O
MCH-30.1	O
MCHC-29.8*	O
RDW-14.3	O
RDWSD-51.4*	O
Plt	O
___	O
___	O
07:20AM	O
BLOOD	O
WBC-8.1	O
RBC-3.73*	O
Hgb-11.2	O
Hct-35.2	O
MCV-94	O
MCH-30.0	O
MCHC-31.8*	O
RDW-14.6	O
RDWSD-48.6*	O
Plt	O
___	O
___	O
06:10AM	O
BLOOD	O
Glucose-166*	O
UreaN-21*	O
Creat-1.0	O
Na-140	O
K-5.0	O
Cl-103	O
HCO3-26	O
AnGap-11	O
___	O
05:25AM	O
BLOOD	O
Glucose-165*	O
UreaN-25*	O
Creat-1.0	O
Na-140	O
K-4.6	O
Cl-103	O
HCO3-28	O
AnGap-9*	O
___	O
06:23AM	O
BLOOD	O
Calcium-9.5	O
Phos-3.7	O
Mg-1.7	O
___	O
05:25AM	O
BLOOD	O
Calcium-9.4	O
Phos-3.6	O
Mg-1.8	O
Brief	O
Hospital	O
Course:	O
PATIENT	O
SUMMARY	O
FOR	O
ADMISSION:	O
===================================	O
___	O
year	O
old	O
___	O
speaking	O
woman	O
with	O
HTN,	O
recent	O
ischemic	O
CVA,	O
Grave's	O
disease,	O
who	O
presents	O
with	O
weakness,	O
worsening	O
back	O
pain	O
and	O
failure	O
to	O
thrive,	O
found	O
to	O
have	O
UTI,	B-Urinary_tract_infection
thoracic	B-Vertebral_compression_fracture
compression	B-Vertebral_compression_fracture
fracture,	B-Vertebral_compression_fracture
and	O
LLL	O
lesion	O
concerning	O
for	O
malignancy.	O
#Generalized	O
weakness	O
and	O
fatigue	O
#Failure	O
to	O
Thrive	O
#Falls.	O
Patient	O
presented	O
to	O
the	O
ED	O
with	O
generalized	O
weakness	O
and	O
fatigue	O
without	O
evidence	O
of	O
focal	O
weakness	O
or	O
difficulty	O
performing	O
specific	O
tasks	O
(ex	O
brushing	O
hair).	O
Given	O
multiple	O
comorbidities	O
and	O
possible	O
new	O
malignancy	O
of	O
the	O
lung,	O
this	O
is	O
overall	O
concerning	O
for	O
failure	O
to	O
thrive.	O
She	O
has	O
had	O
multiple	O
admissions	O
with	O
falls	B-Falls
and	O
similar	O
presentations	O
and	O
weakness	O
that	O
she	O
says	O
started	O
since	O
her	O
complicated	O
hospital	O
course	O
s/p	O
TAH/BSO.	O
She	O
also	O
has	O
a	O
history	O
of	O
labile	O
BPs,	O
concerning	O
for	O
an	O
orthostatic	O
cause	O
of	O
falls	B-Falls
though	O
orthostatic	O
vital	O
signs	O
are	O
reassuring.	O
Patient	O
has	O
been	O
followed	O
by	O
nutrition	O
who	O
documented	O
good	O
po	O
intake	O
while	O
hospitalized.	O
Given	O
FTT,	O
patient	O
has	O
been	O
evaluated	O
by	O
___	O
with	O
recommendation	O
to	O
transition	O
to	O
rehab	O
after	O
discharge.	O
However	O
family	O
ultimately	O
felt	O
that	O
the	O
patient	O
would	O
do	O
best	O
at	O
home	O
despite	O
recommendation	O
for	O
rehab.	O
Because	O
of	O
this	O
preference,	O
Ms.	O
___	O
remained	O
in	O
hospital	O
until	O
safe	O
home	O
conditions	O
could	O
be	O
secured	O
including	O
increased	O
aid	B-Has_carers
presence	O
at	O
and	O
a	O
bedside	O
commode.	O
She	O
will	O
also	O
go	O
home	O
with	O
___,	O
OT.	O
#UTI.	O
Patient	O
presents	O
with	O
overall	O
weakness	O
and	O
fatigue,	O
found	O
to	O
have	O
nitrites,	O
___,	O
and	O
WBC	O
on	O
UA.	O
She	O
reports	O
urinary	O
urgency	O
at	O
baseline	O
without	O
apparent	O
difference	O
in	O
frequency.	O
Urine	O
culture	O
on	O
admission	O
found	O
to	O
be	O
growing	O
Enterobacter	O
which	O
is	O
resistant	O
to	O
CTX,	O
for	O
which	O
she	O
was	O
transitioned	O
to	O
Macrobid	O
(end	O
date:	O
___.	O
#LLL	O
lesion	O
with	O
concern	O
for	O
malignancy.	O
Patient	O
presents	O
with	O
FTT,	O
fatigue,	O
and	O
weakness	O
with	O
CT	O
chest	O
concerning	O
for	O
possible	O
bronchogenic	O
carcinoma	O
without	O
evidence	O
of	O
metastasis	O
at	O
this	O
time.	O
Given	O
location	O
of	O
lesion	O
and	O
concern	O
for	O
high	O
vascularity,	O
___	O
requested	O
that	O
her	O
ASA	O
be	O
held	O
for	O
five	O
days	O
(held	O
since	O
___.	O
___	O
to	O
arrange	O
follow-up	O
appointment	O
for	O
biopsy	O
after	O
discharge.	O
#T11	I-Vertebral_compression_fracture
compression	B-Vertebral_compression_fracture
fracture	B-Vertebral_compression_fracture
#Osteopenia.	O
New	O
T11	B-Vertebral_compression_fracture
fracture	B-Vertebral_compression_fracture
which	O
may	O
occurred	O
after	O
fall,	B-Falls
also	O
with	O
report	O
by	O
___	O
interpreters,	O
who	O
are	O
familiar	O
with	O
her	O
in	O
the	O
outpatient	O
setting,	O
that	O
she	O
had	O
gotten	O
caught	O
within	O
the	O
revolving	O
doors	O
at	O
her	O
outpatient	O
clinic	O
site	O
(deferred	O
ED	O
evaluation	O
at	O
that	O
time).	O
Evaluated	O
by	O
___	O
who	O
recommended	O
that	O
she	O
wear	O
a	O
TLSO	O
brace	O
at	O
all	O
times	O
when	O
out	O
of	O
bed.	O
Patient	O
should	O
follow-up	O
with	O
Dr.	O
___	O
in	O
___	O
weeks	O
and	O
will	O
require	O
standing	O
AP	O
and	O
lateral	O
films	O
of	O
the	O
T-spine	O
and	O
the	O
L-spine	O
without	O
the	O
brace.	O
At	O
time	O
of	O
discharge,	O
patient	O
refusing	O
to	O
wear	O
TLSO	O
brace	O
and	O
provided	O
with	O
LSO	O
brace	O
however	O
medical	O
recommendations	O
remains	O
TLSO	O
brace	O
to	O
be	O
worn	O
at	O
all	O
times	O
when	O
out	O
of	O
bed.	O
Gabapentin	O
400mg	O
BID	O
started	O
for	O
pain	O
control.	O
#Bilateral	O
lower	O
extremity	O
lymphedema.	O
Patient	O
was	O
evaluated	O
by	O
wound	O
care	O
who	O
recommended	O
ACE	O
wraps	O
around	O
bilateral	O
lower	O
extremities.	O
Patient's	O
brother	O
states	O
that	O
she	O
follows	O
at	O
___.	O
___	O
for	O
wound	O
care	O
for	O
which	O
she	O
gets	O
wrap	O
changes	O
on	O
___	O
and	O
___.	O
___.	O
Patient	O
presented	O
with	O
Cr	O
to	O
1.2	O
from	O
baseline	O
0.8-0.9,	O
which	O
was	O
likely	O
due	O
to	O
pre-renal	O
etiology	O
in	O
the	O
setting	O
of	O
poor	O
po	O
intake,	O
improved	O
with	O
IVF.	O
#HTN.	O
Patient	O
is	O
unable	O
to	O
reliably	O
recount	O
her	O
medications	O
but	O
per	O
___,	O
she	O
is	O
on	O
Irbesartan.	O
Given	O
___,	O
Irbesartan	O
was	O
held	O
initially	O
and	O
restarted	O
at	O
150mg	O
daily.	O
TRANSITIONAL	O
ISSUES	O
=================	O
[	O
]	O
CT	O
chest	O
shows	O
lesion	O
in	O
LLL	O
concerning	O
for	O
possible	O
bronchogenic	O
carcinoma.	O
Following	O
5	O
day	O
washout	O
of	O
ASA	O
requested	O
by	O
___,	O
she	O
will	O
have	O
___	O
guided-biopsy	O
of	O
the	O
lesion,	O
already	O
arranged.	O
[	O
]	O
Patient	O
with	O
recently	O
discovered	O
puncate	O
ischemic	O
stroke	O
and	O
was	O
not	O
discharged	O
on	O
statin	O
due	O
to	O
LDL	O
<70	O
per	O
discharge	O
records.	O
ASA	O
held	O
as	O
above.	O
[	O
]	O
Patient	O
should	O
wear	O
TLSO	O
brace	O
at	O
all	O
times	O
when	O
out	O
of	O
bed	O
and	O
until	O
follow-up	O
with	O
Neurosurgery	O
[	O
]	O
Will	O
require	O
standing	O
AP	O
and	O
lateral	O
films	O
of	O
the	O
T-spine	O
and	O
the	O
L-spine	O
without	O
the	O
brace	O
at	O
Neurosurgery	O
follow-up	O
[	O
]	O
Patient	O
with	O
concern	O
for	O
urinary	O
retention	O
(no	O
difficulty	O
with	O
initiation	O
of	O
stream	O
but	O
would	O
be	O
unable	O
to	O
complete	O
void)	O
given	O
history	O
of	O
bladder/uterine	O
prolapse	O
s/p	O
complicated	O
TAH/BSO.	O
Recommend	O
urogynecology	O
evaluation	O
on	O
discharge	O
[	O
]	O
Lower	O
extremities	O
consistent	O
with	O
lymphedema	O
which	O
were	O
wrapped	O
with	O
ACE	O
wrap	O
after	O
wound	O
care	O
evaluation.	O
Per	O
patient	O
and	O
her	O
brother	O
___,	O
patient	O
is	O
seen	O
at	O
___	O
for	O
wound	O
care	O
with	O
changes	O
done	O
on	O
___	O
and	O
___.	O
Torsemide	O
held	O
given	O
___	O
and	O
indication	O
lymphedema.	O
[	O
]	O
Concern	O
for	O
patient	O
safety	O
given	O
recurrent	O
falls	B-Falls
and	O
inability	O
to	O
recount	O
medications.	O
Please	O
continue	O
to	O
address	O
these	O
issues	O
moving	O
forward.	O
Medications	O
on	O
Admission:	O
The	O
Preadmission	O
Medication	O
list	O
is	O
accurate	O
and	O
complete.	O
1.	O
Allopurinol	O
___	O
mg	O
PO	O
DAILY	O
2.	O
Methimazole	O
5	O
mg	O
PO	O
DAILY	O
3.	O
Donepezil	O
5	O
mg	O
PO	O
QHS	O
4.	O
Albuterol	O
Inhaler	O
2	O
PUFF	O
IH	O
Q6H:PRN	O
wheezing	O
5.	O
budesonide-formoterol	O
160-4.5	O
mcg/actuation	O
inhalation	O
BID	O
6.	O
Docusate	O
Sodium	O
100	O
mg	O
PO	O
BID	O
7.	O
Vitamin	O
D	O
___	O
UNIT	O
PO	O
DAILY	O
8.	O
MetFORMIN	O
(Glucophage)	O
1000	O
mg	O
PO	O
BID	O
9.	O
Metoprolol	O
Succinate	O
XL	O
50	O
mg	O
PO	O
DAILY	O
10.	O
Aspirin	O
81	O
mg	O
PO	O
DAILY	O
11.	O
irbesartan	O
300	O
mg	O
oral	O
DAILY	O
12.	O
Torsemide	O
20	O
mg	O
PO	O
DAILY	O
Discharge	O
Medications:	O
1.	O
Gabapentin	O
400	O
mg	O
PO	O
BID	O
RX	O
*gabapentin	O
400	O
mg	O
1	O
capsule(s)	O
by	O
mouth	O
twice	O
daily	O
Disp	O
#*60	O
Capsule	O
Refills:*0	O
2.	O
irbesartan	O
150	O
mg	O
oral	O
daily	O
RX	O
*irbesartan	O
150	O
mg	O
1	O
tablet(s)	O
by	O
mouth	O
daily	O
Disp	O
#*30	O
Tablet	O
Refills:*0	O
3.	O
Multivitamins	O
W/minerals	O
1	O
TAB	O
PO	O
DAILY	O
4.	O
Albuterol	O
Inhaler	O
2	O
PUFF	O
IH	O
Q6H:PRN	O
wheezing	O
5.	O
Allopurinol	O
___	O
mg	O
PO	O
DAILY	O
6.	O
budesonide-formoterol	O
160-4.5	O
mcg/actuation	O
inhalation	O
BID	O
7.	O
Docusate	O
Sodium	O
100	O
mg	O
PO	O
BID	O
8.	O
Donepezil	O
5	O
mg	O
PO	O
QHS	O
9.	O
MetFORMIN	O
(Glucophage)	O
1000	O
mg	O
PO	O
BID	O
10.	O
Methimazole	O
5	O
mg	O
PO	O
DAILY	O
11.	O
Metoprolol	O
Succinate	O
XL	O
50	O
mg	O
PO	O
DAILY	O
12.	O
Vitamin	O
D	O
___	O
UNIT	O
PO	O
DAILY	O
13.	O
HELD-	O
Aspirin	O
81	O
mg	O
PO	O
DAILY	O
This	O
medication	O
was	O
held.	O
Do	O
not	O
restart	O
Aspirin	O
until	O
after	O
your	O
biopsy	O
14.	O
HELD-	O
Torsemide	O
20	O
mg	O
PO	O
DAILY	O
This	O
medication	O
was	O
held.	O
Do	O
not	O
restart	O
Torsemide	O
until	O
restarted	O
by	O
PCP	O
___:	O
Home	O
With	O
Service	B-Has_carers
Facility:	O
___	O
Discharge	O
Diagnosis:	O
PRIMARY	O
DIAGNOSES	O
=================	O
WEAKNESS	O
FAILURE	O
TO	O
THRIVE	O
UTI	B-Urinary_tract_infection
CONCERN	O
FOR	O
MALIGNANCY	O
T11	B-Vertebral_compression_fracture
COMPRESSION	B-Vertebral_compression_fracture
FRACTURE	B-Vertebral_compression_fracture
___	O
LYMPHEDEMA	O
SECONDARY	O
DIAGNOSES	O
===================	O
HYPERTENSION	O
DIABETES	O
MELLITUS	O
CVA	O
GOUT	O
GRAVES	O
DISEASE	O
Discharge	O
Condition:	O
Mental	B-Delirium
Status:	B-Delirium
Clear	B-Delirium
and	B-Delirium
coherent.	B-Delirium
Level	O
of	O
Consciousness:	O
Alert	O
and	O
interactive.	O
Activity	O
Status:	O
Ambulatory	B-Mobile_with_assistance
-	B-Mobile_with_assistance
requires	B-Mobile_with_assistance
assistance	B-Mobile_with_assistance
or	O
aid	B-Mobile_with_aid
(walker	O
or	O
cane).	O
Discharge	O
Instructions:	O
Dear	O
Ms.	O
___,	O
You	O
were	O
evaluated	O
at	O
___	O
after	O
presenting	O
with	O
back	O
pain	O
and	O
fatigue.	O
You	O
were	O
found	O
to	O
have	O
a	O
fracture	B-Vertebral_compression_fracture
in	O
your	O
back	B-Vertebral_compression_fracture
which	O
will	O
require	O
that	O
you	O
wear	O
a	O
brace	O
whenever	O
you	O
are	O
out	O
of	O
bed	O
until	O
you	O
follow-up	O
with	O
the	O
Neurosurgery	O
team.	O
You	O
worked	O
with	O
physical	O
therapy	O
who	O
feel	O
that	O
rehab	O
will	O
help	O
you	O
to	O
become	O
stronger.	O
You	O
were	O
also	O
found	O
to	O
have	O
a	O
urinary	B-Urinary_tract_infection
tract	B-Urinary_tract_infection
infection	B-Urinary_tract_infection
for	O
which	O
you	O
received	O
antibiotics.	O
On	O
one	O
of	O
your	O
imaging	O
scans,	O
you	O
were	O
noted	O
to	O
have	O
a	O
lesion	O
in	O
the	O
left	O
lung	O
that	O
is	O
concerning	O
for	O
cancer.	O
The	O
next	O
step	O
is	O
to	O
have	O
this	O
lesion	O
sampled	O
to	O
determine	O
if	O
it	O
is	O
cancer.	O
You	O
will	O
need	O
to	O
follow-up	O
with	O
the	O
Interventional	O
Radiology	O
team	O
for	O
biopsy	O
which	O
has	O
been	O
arranged	O
below.	O
We	O
recommend	O
that	O
you	O
wear	O
the	O
TLSO	O
brace	O
every	O
time	O
you	O
are	O
out	O
of	O
bed.	O
It	O
is	O
very	O
important	O
that	O
you	O
take	O
your	O
medications	O
as	O
prescribed	O
and	O
attend	O
your	O
follow-up	O
appointments	O
as	O
listed	O
below.	O
We	O
wish	O
you	O
the	O
best!	O
Your	O
___	O
Team	O
Followup	O
Instructions:	O
___	O

